These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32739892)

  • 1. Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review.
    Twohig H; Owen C; Muller S; Mallen CD; Mitchell C; Hider S; Hill C; Shea B; Mackie SL
    J Rheumatol; 2021 Jun; 48(6):883-893. PubMed ID: 32739892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group.
    Owen CE; Yates M; Twohig H; Muller S; Neill LM; Harrison E; Shea B; Simon LS; Hill CL; Mackie SL
    J Rheumatol; 2019 Oct; 46(10):1360-1364. PubMed ID: 30709960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.
    Helliwell T; Brouwer E; Pease CT; Hughes R; Hill CL; Neill LM; Halls S; Simon LS; Mallen CD; Boers M; Kirwan JR; Mackie SL
    J Rheumatol; 2016 Jan; 43(1):182-6. PubMed ID: 26568595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome Measures in Polymyalgia Rheumatica. A Systematic Review.
    Duarte C; Ferreira RJ; Mackie SL; Kirwan JR; Pereira da Silva JA;
    J Rheumatol; 2015 Dec; 42(12):2503-11. PubMed ID: 26568600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study.
    Yates M; Owen CE; Muller S; Graham K; Neill L; Twohig H; Boers M; Pujades Rodriguez M; Goodman SM; Cheah J; Dejaco C; Mukhtyar C; Nielsen BD; Robson J; Simon LS; Shea B; Mackie SL; Hill CL;
    J Rheumatol; 2020 Sep; 47(9):1379-1384. PubMed ID: 32007937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.
    Mackie SL; Twohig H; Neill LM; Harrison E; Shea B; Black RJ; Kermani TA; Merkel PA; Mallen CD; Buttgereit F; Mukhtyar C; Simon LS; Hill CL;
    J Rheumatol; 2017 Oct; 44(10):1515-1521. PubMed ID: 28765246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR.
    Mackie SL; Arat S; da Silva J; Duarte C; Halliday S; Hughes R; Morris M; Pease CT; Sherman JW; Simon LS; Walsh M; Westhovens R; Zakout S; Kirwan JR
    J Rheumatol; 2014 Apr; 41(4):819-23. PubMed ID: 24488422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review.
    Bolhuis TE; Nizet LEA; Owen C; den Broeder AA; van den Ende CHM; van der Maas A
    J Rheumatol; 2022 Jun; 49(6):627-634. PubMed ID: 35232811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-retest reliability of pain VAS/NRS, stiffness VAS/NRS, HAQ-DI and mHAQ in polymyalgia rheumatica: An OMERACT study.
    Leung JL; Twohig H; Muller S; Maxwell L; Mackie SL; Neill LM; Owen CE;
    Semin Arthritis Rheum; 2023 Oct; 62():152239. PubMed ID: 37429139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.
    Dejaco C; Duftner C; Cimmino MA; Dasgupta B; Salvarani C; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL; Schirmer M;
    Ann Rheum Dis; 2011 Mar; 70(3):447-53. PubMed ID: 21097803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.
    Nothnagl T; Leeb BF
    Drugs Aging; 2006; 23(5):391-402. PubMed ID: 16823992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitions of and Instruments for Disease Activity, Remission, and Relapse in Polymyalgia Rheumatica: A Systematic Literature Review.
    Bolhuis TE; Bosch P; Falzon L; Owen CE; Yates M; Mackie SL; van der Maas A; Dejaco C
    Rheumatology (Oxford); 2024 Aug; ():. PubMed ID: 39133187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of criteria for polymyalgia rheumatica.
    Bird HA; Esselinckx W; Dixon AS; Mowat AG; Wood PH
    Ann Rheum Dis; 1979 Oct; 38(5):434-9. PubMed ID: 518143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance and agreement between different activity scores in polymyalgia rheumatica.
    D'Agostino J; Souki A; Lohse A; Carvajal Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel B; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A; Devauchelle-Pensec V
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38490696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review.
    Huang A; Castrejon I
    Rheumatol Int; 2016 Jul; 36(7):897-904. PubMed ID: 26769433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes in polymyalgia rheumatica.
    Matteson EL; Maradit-Kremers H; Cimmino MA; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Slott Jensen H; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Cantini F; Nannini C; Macchioni P; Pipitone N; Del Amo M; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazelman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Marcus R; Gonter NJ; Maz M; Crowson CS; Dasgupta B
    J Rheumatol; 2012 Apr; 39(4):795-803. PubMed ID: 22422492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
    Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
    J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.